|
1
|
Kislauskis E, Bullock B, McNeil S and
Dobner PR: The rat gene encoding neurotensin and neuromedin N.
Structure, tissue-specific expression, and evolution of exon
sequences. J Biol Chem. 263:4963–4968. 1988.PubMed/NCBI
|
|
2
|
Carraway RE, Mitra SP, Feurle GE and Hacki
WH: Presence of neurotensin and neuromedin-N within a common
precursor from a human pancreatic neuroendocrine tumor. J Clin
Endocrinol Metab. 66:1323–1328. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rovere C, Barbero P, Maoret JJ, Laburthe M
and Kitabgi P: Pro-neurotensin/neuromedin N expression and
processing in human colon cancer cell lines. Biochem Biophys Res
Commun. 246:155–159. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carraway RE, Mitra SP and Spaulding G:
Posttranslational processing of the neurotensin/neuromedin-N
precursor. Ann N Y Acad Sci. 668:1–16. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carraway RE, Mitra SP and Muraki K:
Isolation and structures of xenopsin-related peptides from rat
stomach, liver and brain. Regul Pept. 29:229–239. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bidard JN, de Nadai F, Rovere C, et al:
Immunological and biochemical characterization of processing
products from the neurotensin/neuromedin N precursor in the rat
medullary thyroid carcinoma 6–23 cell line. Biochem J. 291:225–233.
1993.PubMed/NCBI
|
|
7
|
Rovere C, Barbero P and Kitabgi P:
Evidence that PC2 is the endogenous pro-neurotensin convertase in
rMTC 6–23 cells and that PC1- and PC2-transfected PC12 cells
differentially process pro-neurotensin. J Biol Chem.
271:11368–11375. 1996.PubMed/NCBI
|
|
8
|
Kitabgi P: Differential processing of
pro-neurotensin/neuromedin N and relationship to pro-hormone
convertases. Peptides. 27:2508–2514. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao D and Pothoulakis C: Effects of NT on
gastrointestinal motility and secretion, and role in intestinal
inflammation. Peptides. 27:2434–2444. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Davis TP, Burgess HS, Crowell S, Moody TW,
Culling-Berglund A and Liu RH: Beta-endorphin and neurotensin
stimulate in vitro clonal growth of human SCLC cells. Eur J
Pharmacol. 161:283–285. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tallett A, Chilvers ER, MacKinnon AC,
Haslett C and Sethi T: Neuropeptides stimulate tyrosine
phosphorylation and tyrosine kinase activity in small cell lung
cancer cell lines. Peptides. 17:665–673. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moody TW, Chiles J, Casibang M, Moody E,
Chan D and Davis TP: SR48692 is a neurotensin receptor antagonist
which inhibits the growth of small cell lung cancer cells.
Peptides. 22:109–115. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Friry C, Feliciangeli S, Richard F,
Kitabgi P and Rovere C: Production of recombinant large
proneurotensin/neuromedin N-derived peptides and characterization
of their binding and biological activity. Biochem Biophys Res
Commun. 290:1161–1168. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ogura S, Kaneko K, Miyajima S, Ohshima K,
Yamaguchi K and Mochizuki T: Proneurotensin/neuromedin N secreted
from small cell lung carcinoma cell lines as a potential tumor
marker. Proteomics Clin Appl. 2:1620–1627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Villeneuve P, Feliciangeli S, Croissandeau
G, et al: Altered processing of the neurotensin/neuromedin N
precursor in PC2 knock down mice: a biochemical and
immunohistochemical study. J Neurochem. 82:783–793. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shaw C, McKay D, Johnston CF, et al:
Differential processing of the neurotensin/neuromedin N precursor
in the mouse. Peptides. 11:227–235. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carraway RE, Mitra SP and Paradise C:
Characterization of large neuromedin-N using antisera towards
regions of the neurotensin/neuromedin-N precursor. Peptides.
12:601–607. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Nadai F, Rovere C, Bidard JN, Cuber JC,
Beaudet A and Kitabgi P: Post-translational processing of the
neurotensin/neuromedin N precursor in the central nervous system of
the rat. I Biochemical characterization of maturation products.
Neuroscience. 60:159–166. 1994.
|
|
19
|
Yamaguchi K, Abe K, Kameya T, et al:
Production and molecular size heterogeneity of immunoreactive
gastrin-releasing peptide in fetal and adult lungs and primary lung
tumors. Cancer Res. 43:3932–3939. 1983.PubMed/NCBI
|
|
20
|
Miyake Y, Kodama T and Yamaguchi K:
Pro-gastrin-releasing peptide(31–98) is a specific tumor marker in
patients with small cell lung carcinoma. Cancer Res. 54:2136–2140.
1994.
|
|
21
|
Stieber P, Dienemann H, Schalhorn A, et
al: Pro-gastrin-releasing peptide (ProGRP) - a useful marker in
small cell lung carcinomas. Anticancer Res. 19:2673–2678.
1999.PubMed/NCBI
|
|
22
|
Barelli H, Fox-Threlkeld JE, Dive V,
Daniel EE, Vincent JP and Checler F: Role of endopeptidase
3.4.24.16 in the catabolism of neurotensin, in vivo, in the
vascularly perfused dog ileum. Br J Pharmacol. 112:127–132. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Checler F, Amar S, Kitabgi P and Vincent
JP: Catabolism of neurotensin by neural (neuroblastoma clone
N1E115) and extraneural (HT29) cell lines. Peptides. 7:1071–1077.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moody TW, Carney DN, Korman LY, Gazdar AF
and Minna JD: Neurotensin is produced by and secreted from classic
small cell lung cancer cells. Life Sci. 36:1727–1732. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moody TW: Peptide hormones and lung
cancer. Panminerva Med. 48:19–26. 2006.
|
|
26
|
Alifano M, Souaze F, Dupouy S, et al:
Neurotensin receptor 1 determines the outcome of non-small cell
lung cancer. Clin Cancer Res. 16:4401–4410. 2010. View Article : Google Scholar : PubMed/NCBI
|
